Nav: Home

The Lancet: Non-physician health workers lead new approach to lowering risk of world's number one cause of death

September 02, 2019

A substantial reduction in the risk of cardiovascular disease, the world's leading cause of death, can be achieved in a year with a new comprehensive approach, according to a randomised controlled trial of 1,371 adults in two countries published in The Lancet and simultaneously presented at the ESC Congress 2019.

In the 'Hope 4" trial, care was led by non-physician health workers using a computer tablet to help decision-making and working closely with physicians. Non-physician led care was supported by counselling to improve health behaviours in people with high blood pressure, two or more free blood pressure-lowering drugs, a statin, and help from family and friends as treatment supporters. This comprehensive approach reduced participants' blood pressure and risk of a future heart attack or stroke by more than double the amount compared to those who received treatment only from physicians.

Hypertension is the leading cause of cardiovascular disease globally but its control in the community is not adequately managed worldwide - in both poor and rich countries.

"Governments around the world have agreed on an ambitious goal to reduce cardiovascular mortality by 30% by 2030. But we will only achieve this goal if we can find novel ways to remove all barriers to cardiovascular risk reduction, such as access to care, compliance with taking medications, and adoption of healthy behaviours." says Dr Jon-David Schwalm, McMaster University, Canada, who led the research. [1]

The new trial included 1,371 adults aged 50 or older from 30 urban and rural communities across Colombia and Malaysia. Participants had uncontrolled high blood pressure and a raised risk of cardiovascular disease. A pre-trial appraisal identified barriers to following through with medical treatment, including the time and expense of travelling to attend physician visits, lost wages, and costs of drugs.

For the intervention group, which included 14 communities, non-physician health workers led the screening, detection, treatment and control of cardiovascular risk factors. Health workers were able to respond to participants' needs, for example by visiting them at home, providing counselling to improve lifestyles and delivering medications. Prescription recommendations were checked by local physicians, who agreed with health workers' assessments 93% of the time.

Those in the intervention group also received lifestyle counselling from the health workers using guidance from a tablet-based app, support from family or friends they nominated to help them remember to take medications and to improve their likelihood of sticking to lifestyle changes, a free supply of single-pill antihypertensive medications combining two drugs, and a separate statin also provided free of charge.

Participants in the control group (16 communities) were recommended to see their local health-care provider as usual.

After 12 months, participants treated using the combined strategy reduced their estimated risk of developing cardiovascular disease in the subsequent 10 years by half. They also achieved a reduction in blood pressure of over 11 mm Hg and a reduction in LDL cholesterol of nearly 0.5 mmol/L. The proportion of individuals with their blood pressure under control - considered to be less than 140 mm Hg - increased by 69%. In comparison, the proportion of individuals in the control group with their blood pressure under control increased by only 30%. Previous studies have found that that every 10 mm Hg reduction in blood pressure reduces the risk of a major cardiovascular event such as stroke, heart attack, or death by 25%.

Participants in the intervention group attended 94% of planned visits and treatment supporters were present at an average of 74% of them. Supporters were a spouse (48%), offspring (34%), other family (11%) or another individual (7%). At 12 months, 84% of participants were taking two or more antihypertensive medications at 12 months, compared to 65% in the control group. Statin use was 84% at 12 months compared to 38% in the control group. Participants assigned to the intervention also reported an increase in physical activity and improvements to their diet after 12 months. However, there were no significant differences in glucose concentrations, HDL cholesterol, rates of those who stopped smoking, or weight between the two groups. There were no safety concerns with the treatment given.

"The unique design of our strategy demonstrates the value of a comprehensive approach which actively involves family and friends as treatment supporters and care being coordinated by trained non-physician health workers guided by a computer program on tablets for diagnosis and counselling," says Professor Patricio Lopez-Jaramillo from the University of Santander in Colombia. [1]

Fadhlina Majid from the Universiti Teknologi MARA in Malaysia adds: "We hope that our results help persuade governments to provide antihypertensive drugs and statins at low or no cost to people with high blood pressure and develop models of care that include trained non-physicians. Even in high-income countries, the detection, treatment, and control of hypertension and other cardiovascular disease risk factors needs substantial improvements." [1]

The authors note several limitations to their study, including the fact that the method of screening could be considered an intervention in itself. Screening involved a combination of door-to-door household visits, use of community outreach centres and local events in public spaces. It therefore led to the detection of hypertension and treatment in individuals who otherwise were unlikely to have identified. More people in the control communities may have received treatment than would normally have been the case, reducing the real differences in outcomes between them and the intervention group. The results are therefore likely to be an underestimate of the full effects of the strategy. Blinding was not feasible in the study, but the authors note they took several steps to avoid biases.

Writing in a linked Comment, Professor Tazeen Jafar from Duke-NUS Medical School, Singapore, says: "A 30% reduction in premature cardiovascular mortality by the year 2030, relative to 2015, is targeted by Sustainable Development Goal 3.4. HOPE 4 and similar highly important studies should prompt the scientific and legislative communities to rethink scale-up of large, evidence-based approaches to dramatically reduce the burden of uncontrolled hypertension and lower cardiovascular risk. Such bold strategies cannot be ignored."

This study was funded by the Canadian Institutes of Health Research, Grand Challenges Canada, the Ontario SPOR Support Unit, the Ontario Ministry of Health and Long-Term Care, Boehringer Ingelheim, WHO, and the Population Health Research Institute. It was conducted by researchers from the Hope 4 trial (full list at the end of the Article).

The labels have been added to this press release as part of a project run by the Academy of Medical Sciences seeking to improve the communication of evidence. For more information, please see: if you have any questions or feedback, please contact The Lancet press office

[1] Quote direct from author and cannot be found in the text of the Article.

The Lancet

Related Blood Pressure Articles:

Arm cuff blood pressure measurements may fall short for predicting heart disease risk in some people with resistant high blood pressure
A measurement of central blood pressure in people with difficult-to-treat high blood pressure could help reduce risk of heart disease better than traditional arm cuff readings for some patients, according to preliminary research presented at the American Heart Association's Hypertension 2019 Scientific Sessions.
Heating pads may lower blood pressure in people with high blood pressure when lying down
In people with supine hypertension due to autonomic failure, a condition that increases blood pressure when lying down, overnight heat therapy significantly decreased systolic blood pressure compared to a placebo.
The Lancet Neurology: High blood pressure and rising blood pressure between ages 36-53 are associated with smaller brain volume and white matter lesions in later years
A study of the world's oldest, continuously-studied birth cohort tracked blood pressure from early adulthood through to late life and explored its influence on brain pathologies detected using brain scanning in their early 70s.
Blood pressure control is beneficial, is it not?
Until recently, physicians had generally assumed that older adults benefit from keeping their blood pressure below 140/90 mmHg.
The 'blue' in blueberries can help lower blood pressure
A new study published in the Journal of Gerontology Series A has found that eating 200g of blueberries every day for a month can lead to an improvement in blood vessel function and a decrease in systolic blood pressure in healthy people.
More Blood Pressure News and Blood Pressure Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...